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In two-armed randomized clinical trials (RCTs) designed to compare a new treatment 
with a control, a key endpoint is often measured analyzed both at baseline and 
after treatment for two groups. More powerful and precise statistical inferences are 
possible once the between-group comparisons have been adjusted for covariates. In 
this thesis we propose a new method for ordered categorical outcomes which adjusts 
for baseline without relying on any specific assumptions on the data generating 
process. Based on baseline and post-treatment values, data are composed of counts of 
patients who have improved from one category to another, stayed the same or 
deteriorated. Not all patterns are comparable. Hence, the ordering is only partial. We 
develop an approach to test the treatment effects ba ed on comparing each 
observation in one group to each observation in the other group to which it is 
comparable. The power comparisons of this test withfour common approaches are 
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Chapter 1: Introduction 
 
Many randomized trials involve measuring an ordinal outcome at baseline and 
after treatment to determine the effectiveness of treatment. For example, in the 
simplest pretest-posttest designs (only one measurement is made after treatment), 
consider the evaluation of an endovascular approach relative to standard procedure 
for the treatment of abdominal aortic aneurysm. Each patient condition may be 
classified as good (G), fair (F), serious (S) or critical (C). After treating the patient for 
a period of time, their health conditions are again r ted on same scale from good to 
critical. The purpose of such clinical trials is to assess the effectiveness of a new 
treatment relative to a standard control approach in improving the state of patients, or 
in reducing the magnitude of deterioration. 
 
Adjusting between-group comparisons for covariates often improves the 
analysis (Senn, 1989). The most common approaches to adjust for an ordinal 
covariate seem to be treating it as binary, nominal, or continuous.  
 
When the covariate is binary or nominal, the adjustment generally consists of 
comparing outcomes across treatment groups, within each level of the covariate. One 
typical nonparametric test is Fisher’s exact test,   which combines categories to create 
a 2 × 2 table to test homogeneity of each outcome probability among the rows. 




practice as inefficient because ignoring the ordering among the categories or 
collapsing categories will result in a loss of power. 
 
To exploit the ordering, numerical scores may be assigned to the ordered 
categories, and simply subtract baseline values from post-treatment values. The 
primary response variable is then the change on the pain scale from baseline. Thus, 
we have a single vector-valued endpoint which captures both baseline and subsequent 
pain measurements. When the choice of scores is not apparent, integer (equally 
spaced) scores are often assigned. Berger and Ivanova (2001) showed this practice 
generally leads to unnecessarily conservative tests. 
 
By treating the ordinal response variable as continuous, we can use the 
analysis of covariance (ANCOVA) with the post-treatment value as the response 
variable and the baseline values as the covariate (Maurer and Commences, 1988; 
Laird and Wang, 1990). ANCOVA is a merger of ANOVA and regression for 
continuous variables. ANCOVA tests whether certain f ctors have an effect after 
removing the variance for which quantitative predictors (covariates) account. The 
inclusion of covariates can increase statistical power because it accounts for some of 
the variability. 
 
Another method to adjust for baseline is to resort to ordinal regression models 
which utilize the ordinal nature of the data by describing various models of stochastic 




model in ordinal regression is the cumulative logit model which models cumulative 
logits by combining the probability of the event and all events that are ordered before 
it. This model has a complete set of parameter estimates for each cumulative logit 
(that is, multiple intercepts and multiple estimates for each predictor). A popular 
submodel of the cumulative logit models is the propo tional odds model (see Agresti, 
1990). The model assumes that the odds of responses below a given response level 
are constant regardless of the level you pick. The proportional odds model plays an 
immensely important role in the practical application of analysis of categorical data. 
Readers interested in further details are referred to McCullagh, 1980 and Agresti, 
1990. However, compared with design-based non-paramet ic tests, regression based 
tests are less transparent in terms of interpretation and inference. Also, regression 
based methods may not be appropriate when the model d es not fit the data.  
 
In this thesis, we explore a new nonparametric method to adjust for baseline 
which does not rely on any assumptions. Specifically, we consider the information-
preserving composite endpoint (Berger, 2002), which consists of the pair of values for 
each patient, one at baseline and one after treatment,  and determine which of these 
patterns indicate the most improvement. It will turn out that some pairs cannot be 
ranked above, equivalent to or below others, resulting in only a partial ordering. To 
the extent that pairs of categories, and therefore pairs of observations, are 
comparable, the experiment is still informative. We exploit the information that is 





In Chapter 2 we illustrate, through a series of examples, some situations in 
which partial ordering arise in RCTs. In Chapter 3 we present several methods for 
adjusting for an ordinal baseline variable, and explore the partial ordering on the 
outcome levels induced by each. In Chapter 4 we develop an exact approach to 
between-group analysis adjusting for ordinal baseline covariates (Berger, 2004) based 
on the partial ordering discussed in Chapter 3. Three traditional methods for 
categorical data analysis (Fisher’s exact test, ANCOVA, proportional odds 
regression) are introduced in Chapter 5, and we conduct a series of simulations to 
compare these conventional tests with our proposed procedure in term of 












Chapter 2: Partial ordering in clinical trials 
 
 
In this section we define partial orderings and illustrate, through a series of 
examples, how they may arise in RCTs. The partial ordering is defined 
mathematically as a mapping on the product space of the elements of a set into the 
space {>, <, =, ≠}, where a ≠ b indicates that a and b are not comparable, or that none 
of a < b, a = b, or a > b would be accurate. For example, if the set is 1, 2, A, B, then 
there are six pairs of elements,  and one partial ordering on this set might be 1 < 2, 1 ≠ 
A, 1 ≠ B, 2 ≠ A, 2 ≠ B, and A < B. Any partial ordering satisfies reflexivity (a = a), 
and antisymmetry (if a > b, then b < a; if a = b, then b = a; if a < b, then b > a; if a ≠ 
b, then b ≠ a). In addition, a proper partial ordering will sati fy the property of 
transitivity, so that a > b > c implies that a > c (Kolmogorov and Fomin, 1970). 
Partial orderings can arise naturally in a variety of settings within the general guise of 
RCTs. In the remainder of this section we illustrate the diversity of RCT situations 
which result in partial orderings. 
 
Example 2.1 (Partially Ordered Sample Space with a Completely Ordered 
Endpoint) 
Suppose that two patients are randomized to each of the experimental 
treatment E and the standard of care control S, and suppose further that the primary 
efficacy endpoint is trichotomous, with three complete y ordered outcome levels. For 
example, these outcome levels may be cure (C), improvement (I), or failure (F) in the 




are completely ordered (C > I > F), the permutation sample space is only partially 
ordered because the endpoint is ordinal but not interval. To see this, suppose that the 
2 × 3 contingency table (by convention, we list theS row first, then the E row, 
separated by a semi-colon, with columns separated by a comma and listed in order of 
increasing benefit, or F, I, C) is observed to be (1, 1, 0; 0, 1, 1), indicating that in the 
S group there was one F and one I, while in the E group there was one I and one C. 
For simplicity, we may also write this as (F, I; I, C). The permutation sample space is 
the set of 2 × 3 contingency tables that preserve the row margin (2, 2) and the column 
margin (1, 2, 1). With these fixed margins, there ar  two degrees of freedom, so may 
denote a 2 × 3 contingency table (viewed as a point in the permutation sample space) 
by only the first two elements. The observed data are then considered as (1, 1). The 
other points of the sample space are (0, 1) = (I, C; F, I),  (0, 2) = (I, I; F, C), and (1, 0) 
= (F, C; I, I). Clearly, (F, I; I, C) provides the most evidence that E is superior to S, 
and (I, C; F, I) provides the least. But it sis notclear how (I, I; F, C) and (F, C; I, I) 
compare to each other without making judgments concerning the relative spacing 
among C, I, and F. That means it is hard to compare two improved patients to one 
cured patient and another patient with no improvement. 
 
Example 2.2 (Multivariate response with ordinal margin) 
Stevens (1951) distinguishes the classification of scale types as nominal, 
ordinal, interval and ratio scales. However this list is incomplete since only a partial 
order may exist among the categories. More complex order structure arises when a 




margin are ordinal. For instance, consider two binary endpoints, y1 and y2, each 
scored as 0 and 1, with 1 corresponding to the better outcomes. We may consider the 
pair (y1, y2) as a single vector-valued endpoint, ad each patient may be classified as 
(0, 0), (0, 1), (1, 0), or (1, 1). It is clear that (1, 1) > (1, 0) > (0, 0) and (1, 1) > (0, 1) > 
(0, 0), but (1, 0) ≠ (0, 1), which results in a partial order. 
 
Example 2.3 (Censored Data) 
Consider survival data with right-censoring. The usual complete ordering on 
uncensored observations still holds. That is, death at nine months is better than death 
at six months (9 > 6). It remains to compare censored observations to censored and 
uncensored observations. Obviously, equality holds if and only if both the time and 
the censoring indicator are common to the two observations. It seems reasonable to 
define the censored observation to be greater than the uncensored one if and only if 
its time is equal to or greater than the time of the uncensored one (11+ > 11, 6+ > 1). 
If the time of the censored observation is less than t e time of the uncensored one, 
there is no way to compare these quantities. For example, if we were to try to 
compare 6+ to 8, then without assuming some sort of m del which enable us to 
estimate the actual time of death of the patient whose survival time was right-
censored at six months, we would only conclude that 6+ ≠ 8. Two observations with 
different censoring times may or may not be considere  comparable, e.g., 6+ < 10+ or 






Example 2.4 (Missing Data) 
Consider a phase III clinical trial with missing data, where each patient might 
be classified on their final result as missing, failure or success. We can consider 
missing as better than failure but worse than success, or we can just consider that it is 
non-comparable to either one.  
 
Example 2.5 (Adjustment for Ordinal Baseline) 
Consider the evaluation of a new therapy for functional gastro-intestinal 
disorder. Each patient may be classified based on pai  as disabling (D), severe (S), 
moderate (M), mild (L), slight (T), or none (N). Obviously, these six outcome levels 
are completely ordered, but they are different from the outcomes in Example 2.1. 
These outcomes represent a point in time, and not change, so the baseline value needs 
to be considered. Suppose that to enter the study a patient would need to be in one of 
the four categories D, S, M, or L. At the end of the study, the patient can be in any of 
the six states. Then we have a single vector-valued endpoint which captures both 
baseline and subsequent pain measurements (Berger, 2002), with 4 × 6 = 24 partially 
ordered outcome levels, as we will study in detail in Chapter 3. This study is precisely 
the kind of problem that motivated this research. 
 
 




Chapter 3: Adjusting for an ordinal baseline variable by 
inducing partial ordering 
Based on the study described in Example 2.5, the dev lopment of partial 
orderings on the 24 categories is informative. If we ignore the comparison of a given 
category to itself, then there are IJ (IJ – 1)/2 pairs of distinct categories for an I × J 
contingency table, or, with 24 categories, 24(23)/2 = 76 pairs of distinct categories. 
In this section we present several methods for adjusting for an ordinal baseline 
variable, and we can actually linearly order these partial orderings by how many of 
the pairs of categories they treat as comparable. This is important, because 
comparative information derives from comparisons of categories. Hence, a partial 
ordering that compares more pairs of categories will provide a more informative 
analysis. However, as we will see, there is a danger in pretending that certain 
categories can be compared when in fact they cannot. We first present the partial 
ordering for the specific case of the 4 × 6 contingency table (Table 1), then generalize 
to an I × J contingency table. We remark that the orderings are based not on the 
perspective of the patient, who would regard as best starting at L and ending at N, but 
rather from the perspective of the evaluation of the medical intervention. This being 
the case, the most clinical benefit derives then for the (D, N) pattern. 
 
Table 1: The 4 × 6 contingency table of Example 2.5 
Baseline Post Treatment Pain Assessment
Pain D S M L T N
D (D, D) (D, S) (D, M) (D, L) (D, T) (D, N)
S (S, D) (S, S) (S, M) (S, L) (S, T) (S, N)
M (M, D) (M, S) (M, M) (M, L) (M, T) (M, N)




3.1 Stratify by Baseline 
The idea behind stratifying for baseline is that two categories are comparable 
only if they have the same first component (baseline), or are in the same row of Table 
1. Now each category is comparable to five other categories, resulting in (4 × 6 × 5)/2 
= 60 comparable pairs of categories out of 24(23)/2 = 76 pairs of categories.  In 
general, with an I × J contingency table, each row category would be comparable to J 
– 1 categories, and the number of comparable pairs of categories would be IJ (J – 
1)/2, out of IJ (IJ – 1)/2 pairs of categories. Obviously, this is a spar e partial 
ordering, which is tantamount to treating baseline as a nominal variable (when in fact 
it is ordinal), and does not treat as comparable the categories (D, N) and (L, D), even 
though the former represents improvement  from disabling pain to no pain and the 
latter represents degradation from mild pain to disabl ng pain. 
 
3.2 Forward and Backward Stratification 
With forward or backward stratification, two outcome levels are comparable 
only if they have the same first (baseline) or second (post-treatment) component, or 
are in either the same row or the same column of Table 1. Now each category is 
comparable to 5 + 3 = 8 other categories, resulting in (4 × 6 × 8)/2 = 96 comparable 
pairs of categories out of 276 pairs of categories. In general, with an I × J 
contingency table, each category would be comparable to (J -1) + (I – 1) categories, 




– 1)/2 pairs of categories. This partial ordering is still sparse, and still considers (D, 
N) ≠ (L, D).  
 
3.3 Enrichment  
One can enrich the partial ordering of Section 3.2 by making it transitive. 
Thus, if (D, N) > (D, D), which is meaningful because going from disabling pain to 
no pain reflects better on the treatment than starting with disabling pain and 
remaining with disabling pain, and if (D, D) > (L, D), which is also meaningful 
because starting with disabling pain and remaining with disabling pain reflects better 
on the treatment than going from mild pain to disabling pain, then it is only 
reasonable that (D, N) > (L, D). Define two categories as comparable if one 
dominates a category that dominates the other. Any category is then comparable to 
any other category Northeast or Southwest of it (Table 1). To find the total number of 
comparable pairs of categories, consider the four cells (categories), at which a pair of 
rows and a pair of columns intersect (Diaconis and Sturmfels, 1998). This gives 
4!/[(2!)(2!)] = 6 pairs of cells, of which five (all but the upper-left vs. the lower-right) 
are comparable. As there are 4!/[(2!)(2!)] = 6 pairs of rows, and 6!/[(2!)(4!)] = 15 
pairs of columns (Table 1), there are 6 × 15 = 90 pairs of non-comparable categories, 
and 276 – 90 = 186 pairs of comparable categories. In general, with an I × J 
contingency table, there would be I!/[(2!)( I - 2)!] pairs of rows and J!/[(2!)(J - 2)!] 





An equivalent derivation is to start with the IJ (I + J - 2)/2 from Section 3.2, 
and then recognized that symmetry half of the remaining [IJ (IJ – 1) – IJ (I + J -2)]/2 
pairs of categories are comparable, and the other half are not. Yet a third derivation, 
which is also instructive, comes from using the five comparable pairs of categories 
from each of the I!J!/[(2!)( I – 2)!(2!)(J – 2)!] pairs of rows and columns and then 
subtracting away the over count, which is IJ [(I – 2)(J – 1) + (J -2)(I – 1)]/2. This is 
evident because each categories is compared to each of the other (J – 1) categories in 
its row (I – 1) times instead of once, and each category is compared to each of the 
other (I – 1) categories in its column (J – 1) times instead of once. 
 
3.4 Direction of Effect 
The aforementioned partial orderings do not compare come improvement 
categories, such as (L, N), to some worsening categories, such as (M, D). If both 
dimensions are measured on the same scale, then one can enrich the partial ordering 
by considering as comparable pairs of categories which differ in the direction of 
effect. For instance, (M, D) < (M, M) < (L, N). To find the number of comparable 
categories, consider rows r1 and r2 > r1, columns c1 and c2 > c1, such that they are not 
interweaving, i.e., the two columns are either within the interval of the two rows or 
outside the interval. Mathematically, r1 ≤ c1 < c2 ≤ r2 or c1 ≤ r1 < r2 ≤ c2, and both 
equalities cannot hold at the same time. These two pairs will intersect at four cells, 
which give six pairs of cells. All of these are comparable (the upper left vs. lower 




or one the diagonal, but they are not on the diagonl at the same time). Obviously, the 
number of ways to choose the columns from outside the interval (r1, r2) is: 
                                           ))(1( 21 rJr −− . 
The number of ways to choose columns inside the interval (r1, r2), where )1( 12 −− rrI is 
an index function is: 
2/)2)(1( )1(1212 12 −−−−−− rrIrrrr . 
The number of ways to choose one at the endpoint and the other outside the interval 
is: 
)1()( 12 −+− rrJ . 
The number of ways to choose one at the endpoint and he other inside the interval is: 
)1(2 12 −− rr . 
So for a fixed pair of rows, there are: 
)1(2)1()(2/)2)(1())(1(),( 1212)1(12122121 12 −−+−+−+−−−−+−−= −− rrrrJIrrrrrJrrrK rr
 
ways to choose a pair of columns such that they intersect at four cells, of which a total 








where the sum is over all possible pairs of rows (r2 > r1). 
 
In our example of pain, I = 4, J = 6, and there are six possible pairs of rows. 
We find that: 
)112(2)11()26(2/)212)(112()26)(11()2,1( )112( −−+−+−+−−−−+−−= −−IK




5)113(20)36(00)3,1( =−−++−++=K , 
7)114(20)46(2/)214)(114(0)4,1( =−−++−+−−−−+=K , 
70)12()36(0)36)(12()3,2( =+−+−++−−=K , 
7)124(2)12()46(0)46)(12()4,2( =−−+−+−++−−=K , 
80)13()46(0)46)(13()4,3( =+−+−++−−=K . 
So the total number of non-comparable pairs is (15)(6) – (4 + 5 + 7 + 7 + 7 + 8) = 52, 
and the number of comparable pairs is 276 – 52 = 224.  
 
3.5 Compare Non-change 
One additional modification is to consider the non-change categories as 
comparable. None of the previously discusses partial orderings would consider (D, D) 
comparable to (S, S), for example. It is not entirely clear how these categories are to 
be compared. One might argue that all of these categories represent no change, so 
they are all equivalent. However, one could also argue that more baseline pain means 
more room (and need) for improvement, so that (L, L) > (M, M) > (S, S) > (D, D). 
The opposite ranking would result if one were to take the view that the healthier the 
patient is to start with, the easier it is to improve. It is not our intention to resolve this 
issue, but rather to point out that these categories may or may not be considered 
comparable. If they are, then there are k!/[(2!)(k - 2)!] fewer pairs of non-comparable 
cells than in Section 3.4, where k = min(I, J). When I = 4 and J = 6, k = 4, and there 





3.6 Sort by Change 
In Section 3.4 the main diagonal (representing no change) was used as a line 
of demarcation to separate improvement from deterioration. Other diagonals can be 
used the same way. Using all diagonals parallel to the main diagonal in this way, and 
equating all cells within a given diagonal, is tantamount to assigning equally-spaced 
scores assigned to the six pain evaluations (say D = 1, S = 2, M = 3, L = 4, T = 5, and 
N = 6), and then ranking the categories by the change from baseline (delta). This 
would be a complete (and obviously transitive) ordering which would consider all 
276 pairs of categories as comparable. However, the relative spacings among 
categories measured on an ordinal but not an interval scale are unknown (Bajorski 
and Petkau, 1999), so it is artificial to compare ov rlapping changes unless one set 
contains the other. The comparison of pairs of categori s not considered comparable 








Chapter 4: An exact approach based on partial ordering 
In this section we will develop our methodology for constructing an exact 
permutation test based on partial ordering of the baseline outcome pairs of categories. 
We will give the definition of the test statistic and technical details of how to compute 
p-values and power of our test. Theoretically, similar to Fisher’s exact test, this 
approach can be explained as follows. Enumerate all possible tables consistent with 
the given margins, and calculate the statistic value of each. The significance value (p-
value) of the observed table is then the percentage of those test statistics which are no 
less than the observed one. One real life sample is pre ented for better illustration. 
Furthermore, in order to extend the bounds of feasibility of our exact procedure for 
practical use, we explore an efficient algorithm which finds the approximate 




The idea of our approach is that although baseline-outcome pairs cannot be 
ordered completely, a partial ordering can still be o tained based on the relationships 
defined in Chapter 3. Our analysis is based on the partial ordering presented in 
Section 3.5, equating all no-change categories. Then an exact permutation test 





The statistical analysis will be dictated by the design to be a two-armed 
parallel RCT with 1:1 randomization to each of the experimental arm E and the 
standard of care control arm S, and the partial ordering. However, a word of caution 
is required here that a philosophical decision needs to be reached prior to performing 
the analysis. It is desirable to settle whether to treat one category as better than 
another if it does not necessarily reflect superiority of E to S. An extreme example is 
given below to clarify this issue. 
 
Suppose that there are 100 patients randomized to each of E and S. Consider 
that each patient randomized to E has outcome (D, N), and each patient randomized 
to S has outcome (L, N). Then every patient on each arm leaves the study pain-free. 
The difference in outcomes is actually a difference only in the baseline component of 
the outcomes, one of which is 100% disabling pain and the other is 100% slight pain. 
Obviously, going from D to N is better than going from L to N, as discussed in 
Section 3.2. But in the evaluation of one treatment relative to another, can this 
superiority be explained by the difference in treatments? Unless there is selection bias 
(Berger and Exner, 1999), randomization ensures that the baseline distribution within 
each arm is necessarily the same, so the observed diff rence must be a random 
occurrence (Senn, 1994), and the apparent superiority may not be attributable to the 
treatments. This situation can be avoided by stratifying for the baseline pain score in 





Once the issues of partial ordering have been settled, then under the 
hypothesis that active treatment is about the same or superior to control treatment, we 
want to test the hypotheses: 
                    ControlActiveH =:0 , 
                    ControlActiveH A >: . 
Suppose n1 patients have been given the active treatment and n2 patients have 
been given the control treatment. The outcomes are from an I × J contingency table. 
In a two-armed RCT, the data structure is a 2 × IJ contingency table, with two rows 
(one for each of the active and control treatments) and IJ columns, with some partial 
ordering on these IJ columns. The row margins are n1 and n2 respectively. Given the 
two samples and in absence of any further assumption about the samples, the 
modified U-statistic is the ratio of pairs favorable to the active group to the total 
number of informative pairs (pairs that are favorable to one of the two groups), i.e. 
 













>=θ , where )( CAP >  is the probability 
that the active treatment will produce the better outc me and the control will produce 
the worse outcome. While we deal with the ties differently from Munzel and 
Tamhane (2002), we retain the expression “tendentiously larger” for the active group 
if 5.0>θ , or for the control group if 5.0<θ . Under the null hypothesis the cell 




In order to efficiently compute the test statistic based on partial ordering, one 
needs to keep track of the set of comparable cells for each cell in contingency table. 
To this end, a comparison matrix M can be defined in order to calculate the newly 
defined test statistic. For a 2 × 9 contingency table with 3 baseline and 3 outcome 
categories ranging from 1 = best to 3 = worst, partial ordering has a comparison 
pattern of Table 2: 
Table 2: Comparison pattern 
Active
Control (1,1) (1,2) (1,3) (2,1) (2,2) (2,3) (3,1) (3,2) (3,3)
(1,1) = C C A = C A A =
(1,2) A = C A A ≠ A A A
(1,3) A A = A A A A A A
(2,1) C C C = C C A ≠ C
(2,2) = C C A = C A A =
(2,3) A ≠ C A A = A A A
(3,1) C C C C C C = C C
(3,2) C C C ≠ C C A = C
(3,3) = C C A = C A A =
 
In Table 2, A or C means active or control treatment is favored by this comparison, 
“=” means equal treatment effect and “≠” represents non-comparable pairs. Based on 
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aaaaaa K and the control group has n2 







cccccc K , and the 
category levels are less than 9 (this is normal in the practical research), we can rewrite 


















cccccc K  based 
on the formula:  
                                  Baseline × 10 + Post-treatment.  
 
To obtain all possible pair combinations between two reatment groups, the observed 
combination matrix X  has the following form: 
 











































































































1 ccaa decides the position in 
comparison matrix M , and the corresponding values (1, -1 or 0) in matrix M  give us 
the comparison result of this pair of observed values based on the partial orderings. 
Therefore, we can easily calculate the total number of comparable pairs which are 
favorable to the active or control treatment by using matrix M and X  together, i.e., 
the counts of -1 and 1 represent the number of pairs f vorable to active and control 
group respectively. Thus, the test statistic can be easily calculated using the observed 
data. We have developed the S-Plus code, which includes building the comparison 
matrix M and the observed combination matrixX , and providing the value of the test 
statisticT . 
 
4.2 Conditional P-value 
In this section we discuss regarding computations of p-values of the tests we 
have proposed. Exact calculation of the conditional p-value requires enumerating all 
possible tables under fixed row and column margins. The immediate difficulty in 
exact calculation is that the required computation ca very easily grow beyond the 




something that limits implementation of any exhaustive procedures. Next we provide 
technical details for computation of the p-values. 
 
4.2.1 Exact conditional p-value 
One usually looks at a conditional sample space where the entries are 
conditioned on the margins of the contingency table. B cause the marginals are 
sufficient statistics the conditional inference is optimal. Under the null hypothesis of 
no association between row and column categories, th  probability of the sampled 
cr × table with total sample size N is: 























  . 
Recall that a p-value is the probability of the observed data or more extreme 
data occurring under the null hypothesis, thus, for k×2  contingency table in two-
armed CRTs, the conditional probability of obtaining a test statistic that is same as or 


















































where the rejection region is the set }:{' )( obsctc tTx ≥Γ∈=Γ , cΓ  is the set of all 
tables X  with the marginal fixed at c . ],,,[ 21 kcccc L=  is the vector of column 
marginal counts. For size α  level, the critical region is  
                               ]),|(:min[)( 0 αα ≤≥= cHtTPtct . 
 
4.2.2 Monte Carlo estimate of conditional p-value 
Substantial research has been done on exact inference for contingency tables 
over the past decade, in terms of developing both new analysis and efficient 
algorithms for computation. The main problem of applying the exact test is that for 
moderate sized tables, the number of table probability to be enumerated can easily 
reach into the billions. Thus, in order to make our exact procedure feasible for 
practical use, an appropriate algorithm needs to be explored. 
 
It has been shown that the number of possible table grows factorially fast as 
the number of baseline categories, number of outcome categories, or the total sample 
size increases. Thus, the number of operations to enum rate )(cΓ  grows faster than 




much research has been done both in exploring new methods for complete 
enumeration and enhancing Monte Carlo approximation accuracy. 
 
Pagano and Halvorsen (1981) came up with an efficient algorithm which finds 
the exact significance level of JI ×  contingency table without enumerating all 
possible tables. Later in 1983, Pagano and Trichler gave another algorithm which 
reduced the computing time to polynomial time as opposed to exponential time 
otherwise. However, because it involves inverting the characteristic function of the 
statistic, this algorithm is only good for statistic  which are linear combinations of 
either the original observations or the ranks, such as the Wilcoxon test. At the same 
time, Mehta and Patel (1983) gave a network algorithm by recursively summing the 
probability in the required contingency tables, which eventually lead to creation of 
StatXact. Morgan and Blumenstein (1991) gave another algorithm for exact 
conditional tests for hierarchical models in multidimensional contingency tables. Both 
network and Morgan’s algorithms depend on complete enumeration, and will thus 
give the exact p-value. 
 
In this thesis, a Monte Carlo procedure given by Patefield (1981) was 
developed as a function Permu( ) in S-Plus to approximate significance levels of the 
proposed exact test on cr × table. It efficiently generates random tables under fixed 
row and column margins. The idea is as follows: 
Let ija  denote cell counts in a cr × contingency table with the row and 




entry lma  given the entries in the previous rows, i.e. ),,1,1,,1,( cjliaij KK =−=  














































































































.  and )11,11( −≤≤−≤≤ cmrl . The above conditional probability 









 is employed. 
 
To ensure the rest cell counts are at least zero, the range of lma  is such that all 
the factorial terms are non-negative. The conditional expected value of lma  given 
previous entries and the row and column totals is 
 













































Although formula for the conditional probability distribution of  lma  appears 
rather complicated, each of the terms is evaluated s quentially as 1,,1 −= rl K ; 
1,,1 −= cm K  in only a few lines of code. For each ),( ml  the algorithm generates a 
random number, RAND, between 0 and 1. The probability distribution of lma  is then 
accumulated, starting with lma  equal to the nearest integer tolmE . The value of lma  is 
chosen with the required conditional probability when the cumulative probability 
exceeds RAND. Given the fixed marginals, the function Permu( ) can provide one 
sampled table as the output. Thus, the procedure for using our proposed exact test is 
to sample table by a large number of calls of Permu( ) and to estimate the significance 
level by the proportion of samples with a value of the test statistic T  (as we defined 
in Section 4.1) that provides at least as much evidence against the null hypothesis as 










To evaluate the performance of the Monte Carlo procedure, we compare the 
estimated p-values with the exact p-values produced by a complete enumeration of 
tables using a recursive method.  
 
Consider a 62× contingency table with 2 baseline (2 and 3) and 3 outcome 
categories (1, 2, and 3) where 1 = best and 3 = worst. Two sets of RCT samples with 









              
 
The comparisons of the exact and approximate p-values for these two samples 
are listed in Table 4.  
                            Table 4: P-value comparisons 
Sample tobs Type # of Permutations P-value
1 0.8076923 Complete Enumeration 782 0.032
Monte Carlo 500 0.030
2 0.5490909 Complete Enumeration 7,532 0.349
Monte Carlo 1,000 0.346
 
 
As can be seen from the tables, the approximate p-values are reliable whereas 
the time required to generate random tables is much less dependent on sample size. 
The difference between complete enumeration and the Monte Carlo algorithm is quite 
substantial when dealing with large tables, which enables us to easily handle the large 
tables that previously would have been impractical o calculate. 
 
4.3 Power  
The performance of our proposed exact test needs to be evaluated compared to 
other widely used tests in term of power. As a preamble to that investigation we start 
off by discussing the formula involved in the power calculation. 
 
Sample Size Treatment (2,1) (2,2) (2,3) (3,1) (3,2) (3,3) 
1 10 Active 1 1 0 4 2 2 
  10 Control 2 2 3 1 1 1 
2 20 Active 7 3 2 5 2 1 




4.3.1 Exact conditional power 
The exact size α conditional power is computed by integrating the point 
probabilities of each table in sample space under an alternative hypothesis AH  over 







txTobs IcxXPctxTP αθθ )()|()|)(( , 
where ]),|(:min[ 0 αα ≤≥= HctTPtt obs  and cΓ  is the set of all possible tables 
given row and column margins. Due to the discrete nature of the data, the significance 
level α  would not be exhausted fully. 
 
Because of the nice exponential family form, the conditional point probability 
)|( cxXP =θ  has nice form. Let kxx 111 ,,L  and kxx 221 ,,L  represent the samples 
from population aF  (active group) andcF  (control group), which arise from 
multinomial ),( 1.1 πn  and ),( 2.2 πn  respectively, where the s'π  are the associated 
probabilities. Let jji xxc 21 += , the column totals. Thus, for each element in the 
sample space, the point probabilities can be calculted. Under 0H  it has a simple 
form as follows: 
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4.3.2 Exact unconditional power 
It is obvious that when conducting a conditional test we compute the exact p-
value with the marginal responses fixed at their observed values. When designing a 
study, however, the marginal responses that will arise once the data are gathered are 
unknown; a priori we can specify only the distributons of the responses, 1π  and 2π . 
Consequently, we must compute power unconditionally with respect to all possible 
margins. We can then obtain exact unconditional power as the expected value of these 
terms, 





αα θθ , 
where )()()(},:{ 2211.2.1 xXPxXPcCPnncc
cx
j ====+==Ω ∑ ∑
Γ∈
ααα θθθ . 
The computation is practically infeasible since even for a moderate sample 
size, Ω  can be quite large. For example, for 5=K  and 50.2.1 =+ nn , Ω  contains 





Alternatively, to reduce the computational burden we can instead estimate 
exact power from a sample of Ω , given .1n  and .2n . In simulation studies power is 
usually estimated by the crude Monte Carlo estimator,α̂ , which is given by: 
 













where N  is the number of Monte Carlo samples. 
 
We are now in a position to put our methodology to the litmus test. We will 
compare it with Fisher’s exact test, ANCOVA, and proportional odds model via 








Chapter 5:  Comparison with other tests 
In Chapter 4 we have developed an exact approach to between-group analysis 
adjusting for ordinal baseline covariates. In order to evaluate the performance of our 
methodology, we compare it with Fisher’s exact test, ANCOVA and the proportional 
odds model, three widely used tests for categorical data as well to decide if our test is 
really desirable. The choice of which method to use can be determined by analysis of 
the statistical properties of each. An important criterion for a good statistical method 
is that it should reduce the rate of false negative (β ). The β  of a statistical test is 
usually expressed in terms of statistical power (β−1 ). A method that requires 
relatively fewer data to provide a certain level of statistical power is described as 
efficient.   
 
5.1 Other tests for categorical data 
5.1.1 Fisher’s exact test 
Fisher’s exact test is a statistical significance test used in the analysis of 
categorical data where sample sizes are small. It is named after its inventor, R. A. 
Fisher, and is one of a class of exact tests. The test is used to examine the significance 
of the association between two variables in 2 × 2 contingency table. With large 
samples, a chi-squared test can be used in this situation. However, this test is not 
suitable when sample sizes are small or when the "expected value" in any of the cells 




the cells of the table. The Fisher test is, as its name states, exact, and it can therefore 
be used regardless of the sample characteristics. I i  also very useful for highly 
imbalanced tables. 
 
Fisher's exact test is based on exact probabilities from the hypergeometric 
distribution. Under 0H , the exact probability of observing one particular s mpled 
table, given fixed row and column margins, has been given in Section 4.1.2. The one-
sided probability for the Fisher’s exact test is calculated by generating all tables that 
are more extreme than the table given by the user, in the direction specified by the 
one-sided alternative. The p-values of these tables ar  added up, including the p-value 
of the table itself. Because the calculation of Fisher’s exact test involves permuting 
the observed cell frequencies it is also referred to as a permutation test, like our 
proposed exact test in Chapter 4.  
 
In two-armed RCTs, the data often include small andzero cell counts. If the 
response is ordinal, we can combine categories to create a 2 × 2 table by treating the 
ordinal covariate as binary (improved or non-improved). Obviously, this converting is 
inefficient because ignoring the ordering among the categories or collapsing 






5.1.2 Analysis of covariance (ANCOVA) 
In most experiments the scores on the covariates are collected before and after 
the experimental treatment. By treating the ordinal response variable as continuous, 
we can use ANCOVA with the post-treatment value as the response variable and the 
baseline value as the covariate.  
 
ANCOVA, or analysis of covariance is a general linear model with one 
continuous explanatory variable and one or more factors. ANCOVA is a merger of 
ANOVA (analysis of variance) and regression for continuous variables. ANCOVA 
tests whether certain factors have an effect after removing the variance of which 
quantitative predictors (covariates) account. The inclusion of covariates can increase 
statistical power because it accounts for some of the variability. The analysis of 
covariance includes the same assumption as the analysis of variance: independent 
sampling, equal corresponding population variances and normally distributed 
corresponding populations. In addition it includes two other assumptions related to 
the relationship between the covariate and the dependent variable. It is assumed that 
the covariance between the covariate and the dependnt variable, within each sample 
or column, do not differ significantly from each other. In other words, if we were to 
compute prediction equations within each sample or column, the slopes of the lines 
would not differ significantly from each other. It is also assumed that the relationship 
between the covariate and the dependent variable is linear--that the relationship is 





In this thesis, the ANCOVA model is written as: 
 
                      ,ijijiij xY εβαµ +++=   inji ,,1;2,1 L==  ,    
                                     
where ijY  is the response of the  j-th unit, receiving treatment i with associated 
baseline covariates ijx . In this model, the effect of the i-th treatment is modeled via 
the parameter iα . The i values 1, 2 represent the active and control treatm n  
respectively.  
 
Now, our interest of examining whether or not there is any treatment effect 
becomes to test the null hypothesis 210 : αα =H  against the alternative hypothesis 
21: αα <AH  (lower level is better). The p-value can be derived by using the F 
distribution. Readers interesting in further details about the computation of p-value 
are referred to Rencher, 2000. 
 
5.1.3 Proportional odds model  
The most well-known cumulative logit model for ordinal response is the 
proportional odds model. Under this model, we assume that the log of the cumulative 
odds ratio is proportional to the distance between the values of the explanatory 
variables.  
 
Let Y be an ordinal variable with k levels, and let )( jYP i ≤  be the cumulative 





    .2,1;,,2,1,)( 21 ==+++=≤ ikjjYP ijiii LL πππ  
 
Then we have 1−k  cumulative probabilities to look at, since 1)( =≤ kYP i . Let 
           
























be the cumulative logits. We can incorporate all 1−k  cumulative logits into the 
following model (Agresti, 1990): 
 
                              .1,,1,')]([logit −=+=≤ kjXjYP j Lβα  
where β  denotes the effects of explanatory variables X . The covariate X  can be 
continuous or categorical. In our case, there are two explanatory variables: binary 
treatment factor (active or control) and ordinal baseline variable.  
 
The above cumulative logit model satisfies 
 




























βαβα   
 
The odds of making response j≤  at aXX =  is )]('exp[ ca XX −β  times the odds 
at cXX = . The log cumulative odds ratio is proportional to the distance between aX  




models simultaneously fit all 1−k  logit models for the k  categories of the response. 
There are different methods to fit the proportional odds model. In this thesis, we use 
GEE (Generalized Estimating Equations) by using the GENMOD procedure in SAS 
to estimate the parameters. See Liang, Zeger and Qaqish (1992) and Lipsitz, Kim and 
Zhao (1994) for a description of GEE methods for ordinal responses. 
 
5.2 Simulations: Comparison of performance 
5.2.1 Methods 
As comparison we employ the three common tests in the previous section and 
our proposed exact permutation test based on partial o dering. We compare more 
generally the unconditional power of these four one-sid d tests (active is better than 
control) in moderate and small samples.  
 
Let us consider the 2 × 3 contingency tables with 2 baseline and 3 outcome 
categories ranging from 1 = best to 3 = worst. In atwo-armed RCT, the data structure 
is 2 × 6 contingency tables, with the active samples from multinomial ),( 1.1 πn  and 
the control samples form multinomial ),( 2.2 πn , where the π ’s are the associated 
transition probability vectors from baseline to post-treatment. The initial probabilities 
to generate the baseline data is (0, 0.55, 0.45). Nine sets of transition probability 






                                Table 5: Transition Probabilities 
No. Transition Probabilities 
π1 (0.63, 0.23, 0.14; 0.56, 0.26, 0.18) 
π2 (0.54, 0.27, 0.19; 0.49, 0.29, 0.22) 
π3 (0.45, 0.30, 0.25; 0.42, 0.31, 0.27) 
π4 (0.36, 0.33, 0.31; 0.35, 0.33, 0.32) 
π5 (0.30, 0.33, 0.37; 0.29, 0.32, 0.39) 
π6 (0.27, 0.32, 0.41; 0.25, 0.30, 0.45) 
π7 (0.18, 0.30, 0.52; 0.14, 0.23, 0.63) 
π8 (0.12, 0.25, 0.63; 0.07, 0.16, 0.77) 
π9 (0.03, 0.13, 0.84; 0.01, 0.04, 0.95) 
 
For each iπ , the first three components are the conditional probabilities of 
falling in category 1, 2, 3 after treatment given that the initial level 2 (sum = 1); the 
last three components represent the conditional probabilities of falling in category 1, 
2, 3 category given that the baseline level is 3 (sum = 1). From Table 4, it can be seen 
that with the index number increases, the transition probabilities more and more shift 
to the higher level, which means given the same baseline values, the sample 
generated from iπ  tends to be better than the one generated from jπ  if ji < . The 
initial probabilities are always same for two treatment groups; however, due to 
sampling error, with random assignment of subjects to the groups, the baseline status 
may differ between treatment groups, that is, they may have same distributions with 
different realizations. By choosing different combinations of set of transition 
probabilities and sample sizes, we generate a variety of datasets for different cases. 
For equal treatment effects ( :0H Active = Control is true), the same transition 
probabilities are used; for unequal treatment effects (explicitly :AH Active > Control 




smaller than cπ  for control group. For each combination of set of transition 
probabilities and sample sizes, we generate 500 pseudo-datasets by sampling from the 
baseline distribution and the distribution created by the given set of the transition 
probabilities and find out how many of the 500 p-values are under significance level 
=α 0.1 or 0.05, i.e. the unconditional power.  
 
5.2.2 Results 
Simulation 1:  
Table 6 displays the power of the four tests for all possible combinations of 
set of transition probabilities, when 30.2.1 =+ nn , in balanced ( .2.1 nn = =15) samples. 
To compute the p-value for our proposed exact test ba ed on the partial ordering, we 
randomly selected 1000 permutations of the treatment groups (subject to Monte Carlo 
sampling) and recomputed the test statistic. As we mentioned in Chapter 4, this set of 
1000 values serves as the null reference distribution for this exact permutation test. 
For simplicity, ),(),( jica ππππ =  is abbreviated as ji − . Power performance 
comparisons for {1-1, …, 1-8}, {2-2, 2-3, …, 2-9}, …, {6-6, 6-7, …, 6-9} for 
1.0=α  (similar curves were observed for 05.0=α ) are shown in Figure 1. 
 
The results show that when the active experiment is slightly better than the 
control treatment, the proportional odds model gives the highest power among these 
four tests and the partial ordering test is more powerful than ANCOVA and Fisher’s 
























































































































































treatment, the power of ANCOVA grows fastest and becomes most powerful while 
the partial ordering  is less powerful than ANCOVA and proportional odds model. As 
we expected, Fisher’s exact test is the worst one. Additionally, all these tests are 
conservative and partial ordering test is kind of less conservative than others. 
 
Simulation 2: 
Power increase when sample size increases. Next we evaluate the effects of 
sample size on the tests. One thousand permutations were selected to compute the p-
value for our proposed exact test with α = 0.1. Table 7 shows the power of the four 
tests with transition probabilities {1-1, …, 1-7}, for sample size }50,30{.2.1 =+ nn  in 
balanced ( .2.1 nn = ) samples. The plot for each test is shown in Figure 2. 
 
         Table 7:  Simulation 2, Balanced Data, N= {30, 50}  











25*2 1-1 0.008 0 0 0 
  1-2 0.058 0 0 0.124 
  1-3 0.232 0.018 0.158 0.516 
  1-4 0.656 0.46 0.922 0.892 
  1-5 0.934 0.92 1 0.998 
  1-6 0.978 0.994 1 1 
  1-7 1 1 1 1 
15*2 1-1 0.016 0 0 0 
  1-2 0.02 0 0 0.068 
  1-3 0.134 0 0.046 0.214 
  1-4 0.428 0.02 0.576 0.52 
  1-5 0.826 0.432 0.934 0.898 
  1-6 0.852 0.74 0.986 0.948 






















































































              Figure 2(b): Simulation 2, balanced samples, N = {30, 50}, α = 0.1 
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Obviously, the power of the proportional odds test increases more quickly 
when the difference of two treatments is small and partial ordering is the second 
position; when the active experiment outperforms control treatment in a large scale, 
the ANCOVA test rises in power most quickly and becomes the most powerful test. 
Proportional odds test is still powerful. The power cu ves of the partial ordering and 
Fisher’s exact test seem to have the similar slopes and their power does not change as 
dramatically as the other two with larger sample siz .  
 
Simulation 3: 
From Simulation 1 and 2, we can conclude that partial ordering test tends to 
be less powerful than ANCOVA and proportional odds te t when the active 
experiment is much better than the control treatmen. Therefore, in the following 
simulations we only focus on the case that the difference between the two treatments 
is small. 
 
Based on the results from Simulation 1, we slightly increase the sample size 
from 30 to 40 in balanced samples with transition probabilities {1-1, 1-2, 1-3, 1-4}, 
{2-2, 2-3, …, 2-6}, …, {4-4, 4-5, 4-6, 4-7} and α = 0.1. One thousand permutations 
for partial ordering were selected for each sample.  Figure 3, 4, 5, 6 show the 
differences in power between these tests. 
 
The comparison results show that for the case of small difference between the 




























































































































































































       Figure 6: Simulation 3, {4-4,…, 4-7}, balanced samples, N= {30, 40}, α = 0.1 
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partial ordering over ANCOVA is increased for some cases, and decreased for other cases. 
The possible reason is that the slight increase of the sample size may be not big enough to 
improve the power performance significantly for ANCOVA method. 
 
Simulation 4: 
In this simulation, we increase the sample size from 30 to 80, in balanced 
samples, α=0.1. From the results of Simulation 1, we choose some points of ),( ca ππ  
where the power of partial ordering is higher than ANCOVA for small sample size. 
The results are shown in Table 8 and Figure 7. 
 
                      Table 8: Simulation 4, balanced samples, N = {30, 80} 










15*2 1-3 0.134 0 0.046 0.214 
  2-4 0.164 0.002 0.006 0.23 
  3-5 0.152 0.004 0.028 0.198 
  3-6 0.306 0.054 0.27 0.52 
  4-6 0.068 0.004 0.04 0.168 
  5-7 0.168 0.012 0.152 0.362 
  6-7 0.13 0 0.02 0.304 
  7-8 0.078 0 0 0.114 
40*2 1-3 0.532 0.284 0.768 0.89 
  2-4 0.528 0.266 0.842 0.902 
  3-5 0.45 0.242 0.698 0.866 
  3-6 0.718 0.63 1 0.976 
  4-6 0.236 0.048 0.174 0.612 
  5-7 0.618 0.55 1 0.958 
  6-7 0.37 0.152 0.528 0.782 














































               Figure 7: Simulation 4, balanced samples, N= {30, 80} α = 0.1 
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Form the plots, it can be seen that for most of the points, ANCOVA is more 
powerful than partial ordering in large sample N = 80. This means that for large 
sample size, even if the difference of two treatments is small, partial ordering is less 
powerful than ANCOVA and proportional odds test. Fisher’s exact test always gives 
the lowest power.  
 
Simulation 5: 
 Since our partial ordering does not show the obvious advantage over 
ANCOVA and proportional odds model, we decrease the sample size to 20 in 
balanced samples, to evaluate the power performance of our test. Five hundred 
permutations were selected to compute the p-value of partial ordering for each sample 
with α = 0.1. Table 9 and Figure 8 display the results. 
                        
                               Table 9: Simulation 5, balanced sample, N=20  










10*2 1-1 0.034 0 0.01 0.02 
  1-2 0.036 0 0.004 0.012 
  1-3 0.082 0.012 0.034 0.112 
  1-4 0.216 0.052 0.22 0.248 
  1-5 0.354 0.102 0.298 0.466 
  2-2 0 0 0 0 
  2-3 0.03 0 0 0 
  2-4 0.144 0.004 0.098 0.132 
  2-5 0.338 0.06 0.174 0.404 
  2-6 0.416 0.078 0.304 0.446 
  3-3 0.008 0 0 0 
  3-4 0.026 0.002 0.02 0.06 
  3-5 0.036 0.008 0.024 0.094 
  3-6 0.064 0.008 0.03 0.104 
  4-4 0.008 0 0 0 
  4-5 0.03 0 0 0 
  4-6 0.03 0 0 0.048 
  4-7 0.286 0.156 0.522 0.434 
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From the results, we can conclude that our partial ordering method shows 
great superiority over other tests in very small sample if the tiny difference between 
two treatments exists. Partial ordering is overall more powerful than ANCOVA and 





                       Table 10: Simulation 6, unbalanced samples, n1. =15,  n2.=10 
                       










Act=15 1-1 0.006 0 0 0 
Con=10 1-2 0.02 0 0 0 
  1-3 0.182 0 0.05 0.026 
  1-4 0.38 0 0.318 0.246 
  1-5 0.648 0.09 0.72 0.398 
  1-6 0.78 0.102 0.88 0.488 
  1-7 0.948 0.944 0.994 0.958 
  1-8 0.998 0.998 1 0.994 
  2-2 0.006 0 0 0 
  2-3 0.028 0 0 0 
  2-4 0.156 0 0.214 0.056 
  2-5 0.318 0.036 0.27 0.12 
  2-6 0.396 0.058 0.43 0.208 
  2-7 0.892 0.828 0.964 0.858 
  2-8 0.99 0.992 0.996 0.952 
  2-9 1 1 1 1 
  3-3 0.004 0 0 0 
  3-4 0.048 0 0.04 0 
  3-5 0.122 0.006 0.062 0.036 
  3-6 0.116 0 0.164 0.026 
  3-7 0.786 0.46 0.93 0.698 
  3-8 0.948 0.846 0.998 0.878 









































































          Figure 9(b): Simulation 6, unbalanced samples, n1. =15, n2. = 10, α = 0.1 
 
Our previous simulations are based on balanced samples. A test based on 
balanced samples will be powerful than the unbalanced ones. Table 10 displays the 
power comparison for unbalanced small samples with size of active group n1. =15 and 
size of control group n2. = 10, given α = 0.1. The plots are shown in Figure 9. 
 
By contrast, proportional odds model is always less powerful than partial 
ordering and ANCOVA. When the difference between two treatments is small, our 
partial ordering has the best performance in terms of power; otherwise, ANCOVA is 
the most powerful test among these four tests. Not surprisingly, the power of Fisher’s 
exact test is lowest.  
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Chapter 6:  Conclusion 
 
6.1 Applications 
Ordinal categorical data arise frequently in a wide variety of experimental 
studies. For example, in clinical trials comparing anti-inflammatory drugs in 
Rheumatoid arthritis, joint pain is often measured on an ordinal scale such as severe, 
moderate, little or none. A multi clinic study of analgesics relief of headache is 
recorded in ordinal responses as well.  We can keepon going because the number of 
examples is really unlimited. 
 
Such abundance of real examples makes statistical an lysis of ordered 
categorical data an important field of study. In this thesis we focus on two-armed 
clinical trials designed to compare a new treatment to a control where for each patient 
an ordered categorical response is observed on entry to the study and at a single 
follow-up evaluation.  Typically in an RCT where data arise from independent 
samples from two populations, each with same k  distinct ordered categories, the 
problem is to test whether there is difference in the two multinomial populations. We 
have developed a new class of ordinal statistics that adjust for baseline differences 
based on partial ordering the baseline, post-treatmnt pairs. We have devoted a 
significant proportion of this thesis to compare thpower performance of our test to 
those commonly used tests, Fisher’s exact test, ANCOVA and proportional odds 
model, for categorical data analysis. Through a variety of simulation studies based on 
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2 × 6 contingency tables, we conclude that in small b lanced or unbalanced samples, 
out test tends to outperform other three tests when t  new experiment is slightly 
better than the control treatment, which is the normal case in practical studies. Thus, 
we provide a good option to conduct the statistical analysis if the sample size is 
limited or unbalanced. Also, clinical trials would have much greater sensitivity if this 
simple, but comprehensive, nonparametric methods can be used.  
 
6.2 Future Work 
          One big concern about our simulation is the conservativeness of four tests 
involved. The mid-P-value, described by Lancaster (1961), modifies the exact test so 
that it rejects more often. For a test statistic T  with observed value obst  and one-sided 
AH  such that large T  contradicts 0H , 
 
                     )(
2
1
)|( obsobs tTPctTPvaluePMid =+>=−− , 
 
with probabilities calculated from the null distribution. Thus, the mid-P-value is lee 
than the ordinary p-value by half the probability of the observed result. Unlike an 
exact test with ordinary p-value, a test using the mid-P-value is less conservative. 
Although this test was not evaluated here, it may be particularly useful for our 
proposed test. Also, the conservativeness of other tests needs to be investigated 
deeply.  
 
Secondly, it has been shown that our proposed test is not the most powerful 
test for all cases. Also it is really hard to find an optimal test for our problem (Berger 
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and Ivanova, 2002). Our research based on the power performance in some common 
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